2020
Prosocial polio vaccination in Israel
Wells CR, Huppert A, Fitzpatrick MC, Pandey A, Velan B, Singer BH, Bauch CT, Galvani AP. Prosocial polio vaccination in Israel. Proceedings Of The National Academy Of Sciences Of The United States Of America 2020, 117: 13138-13144. PMID: 32457142, PMCID: PMC7293608, DOI: 10.1073/pnas.1922746117.Peer-Reviewed Original ResearchConceptsOral polio vaccineOPV campaignsPolio vaccineVaccination behaviorInactivated polio vaccineGreater vaccination coverageRisk of paralysisProsocial vaccinationVaccination coverageVaccine campaignPolio vaccinationVaccinationInsufficient vaccinationPoliomyelitis eradicationSurveillance programVaccineSporadic outbreaksIsrael MinistryPrimary objectiveProsocial natureParalysisDiseasePolio
2019
Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study
Arifin SMN, Zimmer C, Trotter C, Colombini A, Sidikou F, LaForce FM, Cohen T, Yaesoubi R. Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study. Medical Decision Making 2019, 39: 553-567. PMID: 31268405, PMCID: PMC6786941, DOI: 10.1177/0272989x19859899.Peer-Reviewed Original ResearchConceptsReactive campaignsSerogroup replacementConjugate vaccineOne-time catchPolyvalent meningococcal vaccineRoutine infant vaccinationMeningococcal conjugate vaccineMeningococcal polysaccharide vaccineRoutine infant immunizationCurrent vaccination practicesImportant health benefitsCost-effectiveness thresholdStandard cost-effectiveness thresholdsAgent-based transmission modelVaccination seriesImmunization seriesInfant vaccinationInfant immunizationPolysaccharide vaccineMeningococcal vaccineVaccination practicesPolyvalent vaccineLaboratory confirmationMenAfriVacSerogroups A
2018
Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults
Leeds IL, Namasivayam V, Bamogo A, Sankhla P, Thayer WM. Cost Effectiveness of Meningococcal Serogroup B Vaccination in College-Aged Young Adults. American Journal Of Preventive Medicine 2018, 56: 196-204. PMID: 30573332, PMCID: PMC6340776, DOI: 10.1016/j.amepre.2018.09.020.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsMultivariable probabilistic sensitivity analysesUniversal vaccinationProbabilistic sensitivity analysesLife yearsSerogroup BSocietal perspectiveYoung adultsHealth sector perspectiveUniversal vaccination strategyNeisseria meningitidis serogroup BN. meningitidis serogroup BCost effectivenessU.S. vaccineB vaccinationMeningococcal infectionVaccination strategiesSpecific vaccinesVaccinationSensitivity analysisIncremental costOutbreak responseSector perspectiveCollege entryCommon formAntibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
Yaro S, Lafourcade B, Ouangraoua S, Ouoba A, Kpoda H, Findlow H, Tall H, Seanehia J, Martin C, Ouedraogo J, Gessner B, Meda N, Borrow R, Trotter C, Mueller J. Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign? Clinical Infectious Diseases 2018, 68: 435-443. PMID: 30481265, DOI: 10.1093/cid/ciy488.Peer-Reviewed Original ResearchConceptsPre-vaccination levelsAge groupsBooster campaignAntibody persistenceMeningococcal serogroup A conjugate vaccineSerum bactericidal antibody titersBactericidal antibody titersYounger age groupsOlder age groupsImmunoglobulin G concentrationCross-sectional surveyTime of returnDifferent age groupsConjugate vaccineAntibody titersImmune protectionGeneral populationMass vaccinationSerological surveyComplete returnOlder individualsMass campaignsBurkina FasoGeometric meanBobo-Dioulasso
2016
State-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014.
Bernstein S, North A, Schwartz J, Niccolai LM. State-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014. American Journal Of Public Health 2016, 106: 1879-81. PMID: 27552268, PMCID: PMC5024388, DOI: 10.2105/ajph.2016.303381.Peer-Reviewed Original ResearchConceptsVoting patternsAdolescent vaccination coverageHuman papillomavirusRed statesLocal political settingPresidential election resultsVaccination coverageState-level associationsHealth care access characteristicsPolitical settingsElection resultsTetanus-containing vaccineCultural normsSocial valuesBlue statesAdolescent coverageAdolescent vaccinesMeningococcal vaccinationMultivariable modelVaccination policyPotential confoundingVaccinePolicyBoysGirls
2015
Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso
Tall H, Yaro S, Kpoda H, Ouangraoua S, Trotter C, Lafourcade B, Findlow H, Bai X, Martin C, Nwakamma I, Ouedraogo J, Gessner B, Borrow R, Mueller J. Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso. Clinical Infectious Diseases 2015, 61: s540-s546. PMID: 26553686, PMCID: PMC4639492, DOI: 10.1093/cid/civ519.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnimalsAntibodies, BacterialBlood Bactericidal ActivityBurkina FasoChildChild, PreschoolComplement System ProteinsFemaleHumansImmunoglobulin GInfantMaleMass VaccinationMeningitis, MeningococcalMeningococcal VaccinesNeisseria meningitidis, Serogroup ARabbitsSeroepidemiologic StudiesYoung AdultConceptsAntibody titersSerum bactericidal antibody titersVaccine-eligible age groupsBactericidal antibody titersGeometric mean titersAfrican meningitis beltPopulation-level immunitySpecific antibody titersMass immunization campaignOptimal vaccination strategyImmunoglobulin G concentrationLong-term controlPsA-TTMean titersVaccine coverageProtective antibodiesMeningitis beltBlood drawVaccination strategiesImmunization campaignRabbit complementGroup AHigh seroprevalenceStandardized interviewAge groups
2013
Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty
Mbah M, Medlock J, Meyers LA, Galvani AP, Townsend JP. Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine 2013, 31: 3079-3089. PMID: 23684837, PMCID: PMC3764605, DOI: 10.1016/j.vaccine.2013.04.052.Peer-Reviewed Original ResearchConceptsOptimal vaccine allocationParameter uncertaintiesMathematical modelProbability distributionConsideration of uncertaintiesOutcome measuresVaccine allocationHuman population immunitySeasonal influenza vaccinationControl of influenzaUncertainty analysisFace of uncertaintyInfluenza vaccinationVaccine efficacySeasonal influenzaPopulation immunityUncertaintyEpidemiological dataHigh riskYounger ageYoung adultsEpidemiological parametersOptimal agePrevious recommendationsVaccine
2010
Randomized controlled trial to improve childhood immunization adherence in rural Pakistan: redesigned immunization card and maternal education
Usman HR, Rahbar MH, Kristensen S, Vermund SH, Kirby RS, Habib F, Chamot E. Randomized controlled trial to improve childhood immunization adherence in rural Pakistan: redesigned immunization card and maternal education. Tropical Medicine And International Health 2010, 16: 334-342. PMID: 21159080, PMCID: PMC3763701, DOI: 10.1111/j.1365-3156.2010.02698.x.Peer-Reviewed Original ResearchConceptsStandard care groupMother-child pairsImmunization cardPublic health impactCare groupIntervention groupStudy groupCard groupEnd of followEducation groupDTP immunizationImmunization adherenceEPI scheduleFirst doseImmunization visitsStandard careMaternal educationStudy outcomesSubstantial dropoutHealth impactsImmunizationDTP3ChildrenDoseTrials
2009
Determinants of third dose of diphtheria–tetanus–pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study
Usman HR, Kristensen S, Rahbar MH, Vermund SH, Habib F, Chamot E. Determinants of third dose of diphtheria–tetanus–pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study. Tropical Medicine And International Health 2009, 15: 140-147. PMID: 19930140, PMCID: PMC2858790, DOI: 10.1111/j.1365-3156.2009.02432.x.Peer-Reviewed Original ResearchConceptsEPI centresImmunization dropoutThird doseCohort studyMultivariable log-binomial regression analysisLog-binomial regression analysisCentre of enrolmentStandard care groupMother-child pairsMonthly household incomeClinic visitsFirst doseImmunization centreIndependent predictorsMultivariable analysisCare groupInitial immunizationExpanded ProgrammeDTP1More childrenDoseChildrenRegression analysisImmunizationDTP3
2008
The Vote and Vax Program
Shenson D, Adams M. The Vote and Vax Program. Journal Of Public Health Management And Practice 2008, 14: 476-480. PMID: 18708892, DOI: 10.1097/01.phh.0000333883.52893.c8.Peer-Reviewed Original ResearchConceptsInfluenza vaccinationAdult vaccine recipientsInfluenza-associated illnessAnnual influenza vaccinationInfluenza vaccination seasonCommunity-based clinicsHalf of adultsPublic health agenciesVaccination recipientsVaccine recipientsVaccination seasonRobert Wood Johnson FoundationVaccinationDisease preventionHealth agenciesMajor causePriority groupsOlder AmericansClinicJohnson FoundationLarge-scale deliveryRecipientsDeliveryPercentHospitalization
2007
Lessons from the Failure of Human Papillomavirus Vaccine State Requirements
Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Clinical Pharmacology & Therapeutics 2007, 82: 760-763. PMID: 17971822, DOI: 10.1038/sj.clpt.6100397.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildDrug CostsDrug IndustryFemaleHealth Services AccessibilityHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansLobbyingMandatory ProgramsMass VaccinationMichiganPapillomavirus InfectionsPapillomavirus VaccinesParentsPersonal AutonomyPoliticsPublic PolicySchoolsSexually Transmitted Diseases, ViralState GovernmentTexasTumor Virus InfectionsUnited StatesUterine Cervical NeoplasmsConceptsHuman papillomavirusCervical cancerCervical cancer prevention effortsHPV vaccination programCancer prevention effortsPublic health issueHPV vaccinationGenital wartsVaccination programCancer preventionEffective vaccineGreater prevalenceVaccinePrevention effortsHealth issuesConservative groupGlobal healthVaccinationCancerLicensurePapillomavirusMortalityPrevalenceSubtypesWarts
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply